PITX2 and glaucoma: Nearly 50% of children develop glaucoma [10,26], and several more recent studies have demonstrated that glaucoma occurs in 20–74% of patient subjects with PITX2 pathogenic variants and 44–100% of patient subjects with FOXC1 pathogenic variants [15,27,28].